"FACTORES DE RIESGO  QUE PRONÓSTICAN EL HALLAZGO DE CITOLOGÍAS CERVICALES ANORMALES EN DOS POBLACIONES: MUJERES DE OBREROS DE CONSTRUCCIÓN CIVIL VS MUJERES DE CONTROL EN LA POSTA MÉDICA "CONSTRUCCIÓN CIVIL" ESSALUD, DE JUNIO A  SETIEMBRE DEL 2000"

Borja Velezmoro, Gustavo Adolfo; Franco Villafuerte, David


CAPÍTULO 7


   BIBLIOGRAFÍA




1. Adam E, Kaufman RH, Berkova Z, Icenogle J, Reeves WC. Is human papillomaviruses testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia? Am J Obstet Gynecol 1998; 178:1235-44.

2. Alvarez M. Cáncer de Cuello Uterino: Factores de Riesgo. En: Jornada Educativa de Detección, Diagnóstico y Manejo del Cáncer de Cuello Uterino y Cáncer de Mama para Obstetrices. Instituto de Enfermedades Neoplásicas, Mayo de 1997.

3. Anonymous. Study shows insurers fall short on women's reproductive care. Best's Review; Oldwick. Life/Health insurance edition 1998;99:18.

4. Averette HE, Nguyen H. Cáncer Ginecológico. En: Oncología Clínica. 2da Edición. Publicación Científica 559.

5. Bailie R, Sibthorpe B, Anderson I, Smith L. Data for diagnosis, monitoring and treatment in Indigenous health: the case of cervical cancer. Aust n Z J Public Health 1998;22:303-306.

6. Becker TM, Cosette M, McGought NS, McPherson RS et all. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern hispanic and non-hispanic white women. JAMA 1994;271:1181-1188.

7. Blanc B, Boubli L. Displasias del Cuello Uterino. En: Ginecología. 2da Edición, Editorial Mosby-Doyma. 1993.

8. Braun V, Gavey N. Exploring the possibility of sexual-behavioural primary prevention interventions for cervical cancer. Aust N Z J Public Health 1998;22:353-359.

9. Cannistra SA, Jonathan MN. Medical Progress: Cancer of the Uterine Cervix. N Eng J Med 1996;334:1030-1038.

10. Cannon JM, Blythe JG. Comparison of the Cytobrush Plus Plastic Spatula with the Cervex Brush for obtaining endocervical cells. Obstet Gynecol 1993;82:569-72.

11. Castellanos C, Alvarez M, Ramirez G, Santos C, Mariategui J. Neoplasia Intraepitelias Cervical (NIC). En: Ginecología y Obstetricia: Prevención, Diagnóstico y Tratamiento de Abraham Ludmir. Concytec, Lima-Perú, 1996.

12. Cheek J, Fuller J, Gilchrist S, Maddock, Ballantyne A. Vietnamese women and pap smears. Issues in promotion. Aust N Z J Public Health 1999;23:72-76.

Ficha de Tesis
Tabla de Contenido
PDF del capítulo

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


13. Cliby WA, Dodson MK, Podratz KC. Cervical cancer complicated by pregnancy: Episiotomy site recurrences following vaginal delivery. Obstet gynecol 1994;84:179-82.

14. Dabancens A. Lesiones precursoras del carcinoma escamoso de cuello uterino. En: Ginecología de Alfredo Pérez Sánchez. 2da Edición, Editorial Mediterráneo, 1995.

15. Daly SF, Doyle M, English J, Turner M, Clinch J, Prendiville W. Can the number of cigarettes smoked predict high-grade cervical intraepithelial neoplasia among women with mildy abnormal cervical smears?. Am J Obstet Gynecol 1998;179:399-402.

16. Davis JD, Connor EE, Clark P, Wilkinson EJ, Duff P. Correlation between cervical cytologic results and Gram stain as diagnostic for bacterial vaginosis. Am J Obstet Gynecol 1997;177:532-5.

17. DeMay RM. Cytopathology of false negatives preceding cervical carcinoma. Am J Obstet Gynecol 1996; 175:1110-3.

18. Díaz LA, Kabawat SE. Performance of a fluid-Based, Thin-Layer Papanicolaou Smear Method in the Clinical Setting of an Independent Laboratory and an Outpatient Screening Population in New England. Arch Pathol Lab Med 1999;123:817-821.

19. Doornewaard H, van der Schouw Y, van der Graaf Y, Bos AB, van den Tweel JG. Observer Variation in Cytologic Grading for Cervical Dysplasia of Papanicolaou Smears with the PAPNET Testing System. Cancer (Cancer Cytopathol) 1999;87:178-83.

20. Duarte I, Perez A, Chuaqui R. Citopatología Ginecológica. En: Ginecología de Alfredo Pérez Sánchez. 2da edición, Editorial Mediterráneo, 1995.

21. Edelman M, Fox A, Alderman EM, Neal W, Shapiro A, Silver EJ, Spigland I, Suhrland M. Cervical Papanicolaou Smear Abnormalities in Inner City Bronx Adolescents, Prevalence, Progression and Immune Modifiers. Cancer (Cancer Cytopathol) 1999;87:184-9.

22. Eltabbakh GH, Eltabbakh GD, Broekhuizen FF, Griner BT. Value of Wet Mount And Cervical Cultures at the time of Cervical Cytology in Asymptomatic Women. Obstet Gynecol 1995;85:499-503.

23. Falls, RK. Spontaneous resolution rate of grade 1 cervical intraepithelial neoplasia in a private practice. Am J Obstet Gynecol 1999;181:278-82.

24. Ferran M. SPSS para Windows: Programación y análisis estadístico. Editorial Mc Graw-Hill, 1996.

25. Frable WJ. Reflections on adequacy in cervical/vaginal cytology. Cancer (Cancer Cytopathol) 1999;87:103-4.

26. Genest DR, Dean B, Lee KR, Sheets E, Crum CP, Cibas ES. Qualifying the Cytologic Diagnosis of "Atypical Squamous Cells of Undetermined Significance" Affects the Predictive Value of a Squamous Intraepithelial Lesion on Subsequent Biopsy. Arch Pathol Lab Med 1998;122:338-341.

27. Germain M, Heaton R, Erickson D, Henry M, Nash J, O´Connor D. A comparison of the three most common Papanicolaou Smear collection techniques. Obstet Gynecol 1994;84:168-73.

28. Gorman Ch. Beyond the Pap: What you should know about a new gene test that could someday replace the Pap smear. Time, January 17, 2000.

29. Gupta D, Balsara G. Extrauterine Malignancies: Role of Pap Smear in diagnosis and management. Acta Cytol 1999;43:806-813.

30. Hancock L, Fisher S, Kentish L. Cervical cancer screening in rural NSW: Healt Insurance Commission data compared to self-report. Aust N Z J Public Health 1998;22:307-312.

31. Hasenyager C. Knowledge of cervical cancer screening among women attending a university health center. J Am Coll Health 1999;47:221-4

32. Hatch KD, Hacker NF. Enfermedad intraepitelial de cuello uterino, vagina y vulva. En: Ginecología de Novak. 12va Edición. Editora McGraw Hill, 1997.

33. Herbst AL. Detection, prevention, and treatment of cervical of cervical neoplasia: The clinical challenge. Am J Obstet Gynecol 1996; 175:1087.

34. Hildesheim A PhD, Hadjimichael O MPH, Schwartz P MD, Wheeler C PhD, Barnes W MD, Lowell D MD, Willett J MD, Schiffman MD. Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol 1999;180:571-7.

35. Hunt C, Lawton G, Straton J. Pap smear screening at an urban aboriginal health service: Report of a practice of recruiment strategies. Aust N Z J Public Health 1998;22:720-725

36. International Academy of Cytology. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. Acta Cytol 1993;37:115-123.

37. Kaufman RH, Adam E. Is human papillomavirus testing of value in clinical practice?. Am J Obstet Gynecol 1999;180:1049-53.

38. Kirkman-Liff B DrPH, Jacobs J PhD. Access to Cancer Screening Services for Women. Am J Public Health 1992;82:733-735.

39. Kiviat N. Natural history of cervical neoplasia: Overview and update. Am J Obstet Gynecol 1996; 175:1099-104.

40. Kobak W, Roman LD, Felix JC, Muderspach LI, Schlaerth JB, Morrow CP. The role of endocervical curettage at cervical conization for high-grade dysplasia. Obstet Gynecol 1995;85:197-201.

41. Korn A MD, Autry M MD, DeRemer P RN, NP, MS, Tan W. MD. Sensitivy of the Papanicolau Smear in Human Inmunodeficiency Virus-Infected Women. Obstetric Gynecol 1994;83:401-4.

42. Kurman, RJ, Amin MB. Protocol for the Examination of Specimens From Patients With Carcinomas of the Cervix. Arch. Pathol Lab Med 1999;123:55-61.

43. Lazcano-Ponce E, Nájera-Aguilar P, Buiatti E, Alonso-de-Ruiz P, Kuri P, Cantoral L, Hernández-Avila M. The cervical cancer screening program in Mexico: problems with acess and coverage.Cancer Causes and Control, 1997,8 pp.698-704.

44. Lee M PhD, Lee F MPH, Stewart S PhD. Pathways to Early Breast and Cervical Detection for Chinese American Women. Health Education Quarterly, Vol. 23(Supplement):S76-S88(December 1996).

45. Linder J, Zahniser D. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology. Arch Pathol Lab Med 1998;122:139-144.

46. Loeches MM, Asins E, Llixiona J, Cazorla E, Bernebeu JR, Viñas T. ¿Influye la edad en el pronóstico de las pacientes afecta de cáncer de cuello uterino tratadas mediante cirugía radical? Prog Obstet Ginecol 1999;42:669-677.

47. Lonky NM, Navarre GL, Saunders S, Sadeghi M, Tasidk GW. Low-Grade Papanicolaou Smears and the Bethesda System: A prospective cytohistopathologic analysis. Obstet Gynecol 1995;85:716-20.

48. Lonky NM, Sadeghi M, Tsadik GW, Petitti D. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. Am J Obstet Gynecol 1999;181:560-6.

49. Maneta A, Keefe K, Lin F, Ahdoot D, Kaleb V. Atypical glandular cells of undetermined significance in cervical cytologic findings. Am J Obstet Gynecol 1999;180:883-8.

50. Mango LJ. Reducing false negatives in clinical practice: The role of neural network technology. Am J Obstet Gynecol 1996; 175:1114-9.

51. Ministerio de Salud – Perú. Plan Nacional de Prevención del Cáncer Ginecológico: Cuello Uterino y Mama. 1998 – 2000.

52. Ministerio de Salud – Perú. Registro de Cáncer de Lima, 1990-1991.

53. Montes MA, Cibas ES, DiNisco SA, Lee KR. Cytologic characteristics of anormal cells in prior “Normal” cervical/vaginal Papanicolaou Smear from women whit a High Grade Squamous Intraepithelial lesion. Cancer (Cancer Cytopathol) 1999;87:56-9.

54. Moulton D. A better test than Pap smear?. CMAJ 2000;162:689

55. Mount SL, Papillo JL. A Study of 10296 Pediatric and adolescents Papanicolaou Smear Diagnoses in Northern New England. Pediatrics 1999;103:539-545.

56. Noller, KL. Incident and demographic trends in cervical neoplasia. Am J Obstet Gynecol 1996; 175:1088-90.

57. Organización Mundial de la Salud. Anticonceptivos Orales y Neoplasia. Serie de Informes Técnicos 817. 1992.

58. Paraíso MF, Brady K, Helmchen R, Eoat TW. Evaluation of the endocervical Cytobrush and Cervex Brush in pregnant women. Obstet Gynecol 1994;84:539-43.

59. Parazzini F, Sideri M, Restelli S, Schettino F, Chatenoud L, Crosignani PG. Determinants of High-Grade Dysplasia Among Womwn With Mild Dyskaryosis on Cervical Smear. Osbtet Gynecol 1995;86:754-7.

60. Pérez-Stable E MD, Otero-Sabogal R PhD, Sabogal F PhD, Nápoles-Springer A. Pathways to early Cancer Detection for Latinas: en Acción contra el Cáncer. Health Education Quarterly 1996;23 (Supplement):S41-S59.

61. Ransdell JS, Davey DD, Zaleski S. Clinicopathologic correlation of the unsatisfactory Papanicolaou Smear. Cancer (Cancer Cytopathol) 1997;81:139-43.

62. Rapid Communication: The Bethesda System for reporting Cervical/Vaginal Cytologic diagnoses. JAMA 1989;262:931-934.

63. Renshaw AA, Lee KR, Graner SR. Use of Statistical Analysis of Cytologic Interpretation to Determine the Causes of Interobserver Disagreement and in Quality Improvement. Cancer (Cancer Cytopathol) 1997;81:212-9.

64. Renshaw AA. A practical problem with calculating the false-negative rate of Papanicolaou Smear interpretation by rescreening negative cases alone. Cancer (Cancer Cytopathol) 1999;87:351-3.

65. Schiff M, Becker T, Masuk M, Van Asselt-King L, Wheeler C, Altobelli, K, North Ch, Nahmias A. Risk Factors for Cervical Intraepitelial Neoplasia in Southwestern American Indian Women. Am J Epidemiol 2000;152(8):716-726.

66. Schneider A, Zahm DM, Kirchmayr R, Schneider VL. Screening for cervical intraepithelial neoplasia grade 2/3: Validity of cytologic study, cervicography, and human papillomaviruses detection. Am J Obstet Gynecol 1996;174:1534-41.

67. Silverberg SG. Molecular diagnosis and prognosis in gynecologic oncology. Arch Pathol Lab Med 1999;123:1035-1040.

68. Stoler MH. A brief synopsis of the role of human papillomaviruses in cervical carcinogenesis. Am J Obstet Gynecol 1996; 175:1091-98.

69. Trotto NE. Enfermedades de Transmisión Sexual: ¿Está actualizado?. Patient Care 1999; 4-20

70. Vaughn IR, Kozlowski KJ, Warren AM, Hendon A, Davis P. Adolescents and Colposcopy: The Use of Different Procedures to Reduce anxiety. Am J Obstet Gynecol 1994;170:504-508.

71. Veneti S, Papaefthimiou M, Symiakaki H, Ioannidou L. PAPNET for cervical cytology screening: Experience in Greece. Acta Cytol 1999;43:30-33.

72. Ward J, Donelly N, Phoebe H. Impact in general practice of the policies of the organised approach to preventing cancer of the cervix. Aust N Z J Public Health 1998;22:336-341.

73. Warner EA, Parsons AK. Screening and early diagnosis of gynecologic cancer. Med Clin North Am 1996;80:45-61

74. Wismer B, Moskowitz J, Chen A, Kang S et al. Rates and independent correlates of Pap Smear testing among Korean-American women. Am J Public Health 1998;88:665-660

75. Woodhouse SL, Stastny JF, Styer PE, Kennedy M, Praestgaard AH, Davey DD. Interobserver variability in subclassification of squamous intraephitelial lesion: Results of the College of American Pathologist Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 1999;123:1079-1084.

76. Zunzunegui MV, King MC, Coria CF, Charlet J. Male Influences on cervical cancer risk. Am J Epidemiol 1996;123:302-7.

 

 

 

Tabla de Contenido   | Ficha de Tesis



Inicio | Relación por Áreas | Relación por Autor


© 2002 - 2007 UNMSM - Oficina General del Sistema de Bibliotecas y Biblioteca Central
Todos los derechos reservados
Lima - Perú